IGF-1Ea induces vessel formation after injury and mediates bone marrow and heart cross-talk through the expression of specific cytokines

Biochemical and Biophysical Research Communications

Volumn 410, Issue 2, 2011, Pages 201-207

  Santini, Maria Paola ^a   Lexow, Jonas ^a   Borsellino, Giovanna ^b   Slonimski, Esfir ^c   Zarrinpashneh, Elham ^a   Poggioli, Tommaso ^a   Rosenthal, Nadia ^a,c,d  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Angiogenesis; Cardiac regeneration; IGF 1Ea; Side population

Indexed keywords

ATAXIN 1; CD34 ANTIGEN; IGF 1EA PROTEIN; SOMATOMEDIN C; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL LINEAGE; CELL POPULATION; CELL REGENERATION; CONTROLLED STUDY; CYTOKINE RESPONSE; ENDOTHELIUM CELL; GENE EXPRESSION; HEART INJURY; HEMATOPOIETIC STEM CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL MOBILIZATION; TRANSGENE;

ANIMALS; ANTIGENS, LY; BONE MARROW CELLS; CORONARY VESSELS; CYTOKINES; HEART; INSULIN-LIKE GROWTH FACTOR I; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-KIT; REGENERATION; STEM CELLS;

MAMMALIA;

EID: 79959733942     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.081     Document Type: Article

References (28)

1. Penn M.S., Mangi A.A. Genetic enhancement of stem cell engraftment, survival, and efficacy. Circ. Res. 2008, 102:1471-1482.
2. Tateishi K., Ashihara E., Takehara N., Nomura T., Honsho S., Nakagami T., Morikawa S., Takahashi T., Ueyama T., Matsubara H., Oh H. Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration. J. Cell Sci. 2007, 120:1791-1800.
3. Urbanek K., Rota M., Cascapera S., Bearzi C., Nascimbene A., De Angelis A., Hosoda T., Chimenti S., Baker M., Limana F., Nurzynska D., Torella D., Rotatori F., Rastaldo R., Musso E., Quaini F., Leri A., Kajstura J., Anversa P. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium improving ventricular function and long-term survival. Circ. Res. 2005, 97:663-673.
4. Musaro A., Giacinti C., Borsellino G., Dobrowolny G., Pelosi L., Cairns L., Ottolenghi S., Cossu G., Bernardi G., Battistini L., Molinaro M., Rosenthal N. Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. P. Natl. Acad. Sci. USA 2004, 101:1206-1210.
5. Santini M.P., Tsao L., Monassier L., Theodoropoulos C., Carter J., Lara-Pezzi E., Slonimsky E., Salimova E., Delafontaine P., Song Y.H., Bergmann M., Freund C., Suzuki K., Rosenthal N. Enhancing repair of the mammalian heart. Circ. Res. 2007, 100:1732-1740.
6. Oyama T., Nagai T., Wada H., Naito A.T., Matsuura K., Iwanaga K., Takahashi T., Goto M., Mikami Y., Yasuda N., Akazawa H., Uezumi A., Takeda S., Komuro I. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J. Cell Biol. 2007, 176:329-341.
7. Yoon J., Choi S.C., Park C.Y., Shim W.J., Lim D.S. Cardiac side population cells exhibit endothelial differentiation potential. Exp. Mol. Med. 2007, 39:653-662.
8. Wen P.H., De Gasperi R., Sosa M.A., Rocher A.B., Friedrich Jr V.L., Hof P.R., Elder G.A. Selective expression of presenilin 1 in neural progenitor cells rescues the cerebral hemorrhages and cortical lamination defects in presenilin 1-null mutant mice. Development 2005, 132:3873-3883.
9. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 1996, 183:1797-1806.
10. Goodell M.A., McKinney-Freeman S., Camargo F.D. Isolation and characterization of side population cells. Methods Mol. Biol. 2005, 290:343-352.
11. Pitchford S.C., Furze R.C., Jones C.P., Wengner A.M., Rankin S.M. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 2009, 4:62-72.
12. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
13. Askari A., Unzek S., Goldman C.K., Ellis S.G., Thomas J.D., DiCorleto P.E., Topol E.J., Penn M.S. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy. J. Am. Coll. Cardiol. 2004, 43:1908-1914.
14. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., Rovner A., Ellis S.G., Thomas J.D., DiCorleto P.E., Topol E.J., Penn M.S. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003, 362:697-703.
15. Cashen A.F., Link D., Devine S., DiPersio J. Cytokines and stem cell mobilization for autologous and allogeneic transplantation. Curr. Hematol. Rep. 2004, 3:406-412.
16. Jia T., Serbina N.V., Brandl K., Zhong M.X., Leiner I.M., Charo I.F., Pamer E.G. Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. J. Immunol. 2008, 180:6846-6853.
17. Si Y., Tsou C.L., Croft K., Charo I.F. CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. J. Clin. Invest. 2010, 120:1192-1203.
18. Schenk S., Mal N., Finan A., Zhang M., Kiedrowski M., Popovic Z., McCarthy P.M., Penn M.S. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 2007, 25:245-251.
19. Lodie T.A., Blickarz C.E., Devarakonda T.J., He C., Dash A.B., Clarke J., Gleneck K., Shihabuddin L., Tubo R. Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction. Tissue Eng. 2002, 8:739-751.
20. Hirschi K.K., Ingram D.A., Yoder M.C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscl Throm Vasc 2008, 28:1584-1595.
21. Kalka C., Masuda H., Takahashi T., Gordon R., Tepper O., Gravereaux E., Pieczek A., Iwaguro H., Hayashi S.I., Isner J.M., Asahara T. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ. Res. 2000, 86:1198-1202.
22. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999, 5:434-438.
23. Ince H., Petzsch M., Kleine H.D., Eckard H., Rehders T., Burska D., Kische S., Freund M., Nienaber C.A. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor (FIRSTLINE-AMI) trial. Circulation 2005, 112:173-180.
24. Simons M., Annex B.H., Laham R.J., Kleiman N., Henry T., Dauerman H., Udelson J.E., Gervino E.V., Pike M., Whitehouse M.J., Moon T., Chronos N.A. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2:double-blind, randomized, controlled clinical trial. Circulation 2002, 105:788-793.
25. Kang H.J., Lee H.Y., Na S.H., Chang S.A., Park K.W., Kim H.K., Kim S.Y., Chang H.J., Lee W., Kang W.J., Koo B.K., Kim Y.J., Lee D.S., Sohn D.W., Han K.S., Oh B.H., Park Y.B., Kim H.S. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized controlled trial. Circulation 2006, 114:145-151.
26. Nielsen J.S., McNagny K.M. CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation 2009, 16:487-496.
27. Zentilin L., Puligadda U., Lionetti V., Zacchigna S., Collesi C., Pattarini L., Ruozi G., Camporesi S., Sinagra G., Pepe M., Recchia F.A., Giacca M. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. Faseb J. 2009, 24:1467-1478.
28. Zhou Y., Bourcy K., Kang Y.J. Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway. Cardiovasc. Res. 2009, 84:54-63.